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Schizotypy refers to a set of temporally stable traits that are observed in the general pop-
ulation and that resemble the signs and symptoms of schizophrenia. Here, we review
evidence from studies on genetics, cognition, perception, motor and oculomotor con-
trol, brain structure, brain function, and psychopharmacology in schizotypy. We specifically
focused on identifying areas of overlap between schizotypy and schizophrenia. Evidence
was corroborated that significant overlap exists between the two, covering the behav-
ioral brain structural and functional as well molecular levels. In particular, several studies
showed that individuals with high levels of schizotypal traits exhibit alterations in neu-
rocognitive task performance and underlying brain function similar to the deficits seen in
patients with schizophrenia. Studies of brain structure have shown both volume reductions
and increase in schizotypy, pointing to schizophrenia-like deficits as well as possible pro-
tective or compensatory mechanisms. Experimental pharmacological studies have shown
that high levels of schizotypy are associated with (i) enhanced dopaminergic response in
striatum following administration of amphetamine and (ii) improvement of cognitive perfor-
mance following administration of antipsychotic compounds. Together, this body of work
suggests that schizotypy shows overlap with schizophrenia across multiple behavioral and
neurobiological domains, suggesting that the study of schizotypal traits may be useful in
improving our understanding of the etiology of schizophrenia.
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INTRODUCTION
Schizophrenia is a serious psychiatric condition with unknown
etiology characterized by positive symptoms (such as hallucina-
tions and delusions), negative symptoms (such as avolition and
psychomotor poverty), and thought disorder as well as cogni-
tive deficits. The illness has adverse consequences not only for
the sufferers but also their relatives and society at large (1).
Patients with schizophrenia are at significantly increased risk of
suicide and frequently suffer socio-economic disadvantages. The
costs to society include direct costs, such as treatment, as well
as indirect costs, such as loss of manpower at work due to the
illness or due to caring by relatives (2, 3). Current pharma-
cological treatments of schizophrenia are successful at reduc-
ing psychotic symptoms but do not provide a cure (4), espe-
cially given that neurocognitive deficits and negative symptoms
appear less amenable to treatment than psychotic phases of the
disorder.
An important step in advancing etiological research into this
condition was the realization that schizophrenia is not, despite its
clinically important and reliable categorical diagnosis according
to the International Classification of Disease (ICD) of the World
Health Organization or the Diagnostic and Statistical Manual
(DSM) of the American Psychiatric Association, a binary pheno-
type (present, absent) with sudden disease onset. Instead, there is
substantial agreement amongst clinicians and researchers that the
systematic investigation of intra- and inter-individual continua
plays an important role in improving our understanding of the
etiology of the disorder (5–7).
There are at least three different types of continua to be dis-
tinguished in this context: first, retrospective and longitudinal
studies have provided evidence for a temporal continuum. For
example, early motor and cognitive deficits as well as individual
psychotic symptoms are observed in childhood and youth of those
who later develop schizophrenia (8, 9). These signs and symptoms
dramatically increase in the prodrome, immediately before illness
onset (10).
Second, clinical studies of patients with schizophrenia have
shown that even within the clinically meaningful diagnostic bor-
ders of schizophrenia, significant inter-individual differences exist
both in the kind and severity of symptoms as well as in the longi-
tudinal course of the illness. In an influential study, Strauss (11)
observed in a sample of patients that symptoms such as hallucina-
tions or delusions could often not be classified as unambiguously
present or absent. This observation was interpreted as a contra-
diction to the assumption of a binary illness phenotype [(11);
p. 585]: “Hallucinations and delusions are key symptoms in the
conceptualization and diagnosis of schizophrenia. In the past,
their definition as discrete symptoms has been used to substan-
tiate the supposedly discrete nature of this disorder. Recognizing
these symptoms as points on continua implies that schizophrenia
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too might be more adequately described as a point or a series of
points on a functional continuum.”
Third, and of most relevance to this article, a large and con-
tinuously growing body of evidence suggests that certain aspects
of the phenomenology of schizophrenia are also traceable in the
general population, beyond the diagnostic borders of the current
nosological systems ICD and DSM (12). One of the first empirical
investigations of this issue (13) observed in a sample of approxi-
mately 17,000 adults in Victorian England that about 8% of males
and 12% of females reported at least one hallucination in their life-
time [see also Ref. (14)]. More recent systematic investigations by
van Os and colleagues similarly document the existence of indi-
vidual psychotic symptoms in the general population (12). In a
comprehensive review of several population-based studies of the
frequency of psychotic symptoms, it was found that over 8% of the
population reports psychotic experiences and that these could be
explained through the same etiological factors that also increase
risk for non-affective psychoses (12).
In addition to the study of individual psychotic symptoms in
the general population, Johns and van Os (15) proposed that there
is a second approach to investigating population continua. That
approach describes subclinical, attenuated trait-like expressions of
the disorder ranging along a continuum in the form of schizotypal
signs. This schizotypy approach is the focus of the present article1.
Together, the observation of individual psychotic symptoms
and the description of subclinical schizotypal traits in the general
population have led to the concept of the schizophrenia spectrum.
This work is based on the notion of a non-binary distribution
of schizophrenia (12), an assumption that is currently receiving
widespread agreement in the literature (5).
Here, we examine the schizotypy approach in more detail and
then focus on the overlap between schizotypy and schizophrenia.
In doing so, we provide an overview of empirical work pointing
to similarities between the two constructs not only at the level of
phenomenology but also genetics, cognition, perception, motor
control, and neurobiology. The argument proposed on the basis
of these data is that schizotypal traits share not just superficial sim-
ilarity with the signs and symptoms of schizophrenia but appear
related to the clinical disorder at multiple levels of analysis.
PHENOMENOLOGY AND MEASUREMENT OF SCHIZOTYPY
The term schizotypy was coined by Rado (16). The large and
methodologically heterogeneous literature on schizotypy can
broadly be grouped into two approaches, viz. the so-called
quasi-dimensional and fully dimensional approaches (6, 15, 17).
According to Meehl (18, 19), schizotypy is the psychological
and personality organization of most, but not all, individuals with
schizotaxia. Schizotaxia is defined by Meehl as a neural defect due
to a synaptic aberration termed hypokrisia, which is caused by a
1In this context, it is also important to point out that there are associations between
the existence of individual psychotic symptoms and schizotypal traits (44, 218, 219),
which speak for the integration of these two literatures. Such observations are to be
expected under the assumption that higher trait schizotypy scores along the contin-
uum from normal personality to schizophrenia will be associated with increasing
manifestations of psychosis.
single gene, the schizogene. According to Meehl, schizotaxia has
a population base rate of about 10%. Meehl’s quasi-dimensional,
psychiatrically oriented approach considers schizotypy as the sub-
clinical expression of the symptoms of schizophrenia (20, 21).
Evidence for this approach stems from taxometric studies (22),
although there are also failures to provide evidence of a taxon (7).
The fully dimensional approach (23) is rooted in differential
psychology and is based on the work of Eysenck and Claridge
(7, 24–27). This approach treats schizotypy as a personality trait
that is continually distributed in the general population. This trait
shows individual differences and results, at its extreme high end,
in a diagnosis of schizophrenia. Evidence for this approach stems
from taxometric studies that consider positive skewness of sample
distribution (7). The high prevalence of psychotic-like experi-
ences in the general population is also in accordance with the
fully dimensional approach (28, 29).
Theoretical issues aside, both approaches agree that there is
variation in schizotypal features in the population, although spe-
cific details concerning the nature of the distribution (for example,
the question of whether there is a taxon or not) have not been
finally resolved (7, 15, 22).
Schizotypy can be assessed in the general population (30,
31) using clinical interviews [such as the Structured Interview
for Schizotypy (32)] or psychometric self-report questionnaires
[such as the Schizotypal Personality Questionnaire (SPQ (33)), the
Oxford–Liverpool Inventory of Feelings and Experiences (O-LIFE
(34)), the Rust Inventory of Schizotypal Cognitions (RISC (35)),
the Community Assessment of Psychic Experiences (CAPE (36)),
the Schizotypal Personality Scale (STA (37)), the Peters et al. Delu-
sions Inventory (PDI (38)), the Eysenck Psychoticism (P) Scale
(39), or the Chapman scales (40)]. Sample items from the SPQ are
shown in Table 1.
The psychometric structure of schizotypy has been examined
in numerous factor analyses of questionnaire data. Overall, there
appears to be some agreement in the literature that the variance of
schizotypy is well explained by a three-factor structure including
the following dimensions (41). The“cognitive-perceptual”dimen-
sion (also referred to as positive schizotypy) includes percep-
tual alterations that bear some resemblance to the hallucinations
reported in schizophrenia. It also includes unusual thoughts and
views that resemble the delusions of schizophrenia. The “disorga-
nized” dimension includes formal thought disorder and eccentric
behavior. Finally, the “interpersonal” dimension (also referred to
as negative schizotypy) is characterized by the loss of emotional,
physical, and social functions such as pleasure, volition, interest in
social contacts, and emotionality. Altogether the phenomenology
of schizotypy thus possesses considerable similarity with the factor
structure of schizophrenia (42).
The three-factor structure of schizotypy has been recovered
independent of variables such as gender, culture, and religion
(43). Individual differences in schizotypy can be measured with
high reliability and possess high temporal stability (33–35, 44). It
should also be noted that the scores of psychometric self-report
questionnaires correlate highly with observer-ratings gained from
clinical interviews (33, 45), further supporting the validity of these
measures.
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Table 1 | Sample Questionnaire Items for the measurement of schizotypy.
Item SPQ dimension
Do you sometimes feel that things you see on the TV or read in the newspaper have a special meaning for you? Ideas of reference (Pos)
I often hear a voice speaking my thoughts aloud Unusual perceptual experiences (Pos)
I feel I have to be on my guard even with friends Suspiciousness (Pos)
I sometimes jump quickly from one topic to another when speaking Odd speech (Dis)
I sometimes use words in unusual ways Odd speech (Dis)
My “non-verbal” communication (smiling and nodding during a conversation) is not very good Constricted affect (Neg)
I prefer to keep myself to myself No close friends (Neg)
The items are taken from the Schizotypal Personality Questionnaire (SPQ). Pos: the positive dimension of schizotypy; Dis: the disorganization dimension of schizotypy;
Neg: the negative dimension of schizotypy.
GENETIC, COGNITIVE, AND NEUROBIOLOGICAL STUDIES OF
SCHIZOTYPY: OVERLAP WITH SCHIZOPHRENIA?
The description of schizotypy in the preceding section provides
clear evidence of its phenomenological overlap with schizophre-
nia. This evidence is complemented by empirical studies further
investigating such putative overlap on different levels of analy-
sis, namely (1) genetic and non-genetic etiological influences,
(2) cognition, perception, and motor control, (3) brain struc-
ture and function, and (4) psychopharmacology. In the following
part of this article, we will provide an overview of that work.
As will become clear from the following discussion, these stud-
ies provide strong support for similarities between schizotypy and
schizophrenia across these multiple analysis domains.
Due to the large number of studies on schizotypy, the fol-
lowing review is not comprehensive. We do, however, pro-
vide a table summarizing the key details of all available func-
tional magnetic resonance imaging (fMRI) studies of schizotypy
(Table 2).
GENETIC AND ENVIRONMENTAL RISK FACTORS
Behavioral genetic studies estimate the heritability of schizophre-
nia to be approximately 66–83% (60) and that of schizotypy to be
around 30–50% (61–64), although lower estimates have also been
reported for schizotypy (65). Evidence of genetic overlap between
schizophrenia and schizotypy comes from family studies, which
show that first-degree relatives of schizophrenia patients have
increased levels of schizotypy (66, 67), particularly in the negative
dimension (68). In addition to increased mean levels of schizotypy
in the relatives compared to controls without a first-degree relative
with schizophrenia, there are also reports of associations between
the profile and severity of clinical symptoms in the patients and
the dimensions of schizotypy in the relatives (69). For example,
one study showed that the severity of positive symptoms in psy-
chotic patients was associated with the level of positive schizotypy
in the relatives, similar to the findings of another study on neg-
ative schizotypy (70). Overall, these studies provide evidence for
genetic, or at least familial, correlations between schizotypy and
schizophrenia.
More recent molecular genetic data complement these behav-
ioral genetic studies. For example, a genome-wide association
study (GWAS) showed considerable overlap between the genetic
association profiles of schizophrenia and schizotypy (71). Put
together, these molecular genetic studies point to considerable
overlap of schizotypy with schizophrenia at the genetic level by
implicating similar polymorphisms in both phenotypes.
In addition to genetics, environmental risk factors are also
known to play an important role in the etiology of schizophrenia,
including winter or spring birth (72), growing up in an urban area
(73), being an ethnic minority (74), childhood trauma (75), and
cannabis use (76). These factors also increase the risk for subclin-
ical spectrum phenotypes, again supporting the notion of overlap
in etiological factors between schizophrenia and its subclinical
expression (15).
COGNITION, PERCEPTION, AND MOTOR CONTROL
A large body of work has documented cross-domain deficits
in automatic and controlled cognition, perception, and motor
control in schizophrenia. Meta-analyses suggest that the most
pronounced deficits are in the domains of verbal learning and
memory, working memory, attention and executive functions as
well as psychomotor control (77).
Complementing the work on schizophrenia, there have been
numerous investigations of cognition, perception, and motor con-
trol in relation to schizotypy. The overall finding that emerges
from these investigations is that high levels of schizotypy are
associated with subtle performance deficits, mostly compatible
with the pattern of findings observed, albeit at greater severity, in
schizophrenia. The literature on cognition has been qualitatively
reviewed in a number of recent publications (6, 17, 21). A com-
prehensive meta-analysis of the association between all aspects of
cognition, perception, and motor control with schizotypy using
different study designs is missing, although a recent study calcu-
lated effect sizes for measures of cognition in a selection of studies
that included a psychometrically defined schizotypy group drawn
from the population of college students (78). That analysis did
not find a strong effect size for the comparison between schizo-
typy groups and controls, but is limited not only by the sample
inclusion criterion but also the exclusion of neurocognitive mea-
sures such as prepulse inhibition and oculomotor tasks, measures
known to be reliably associated with schizotypy (see below).
Here, the key findings of studies examining the association
between schizotypy and cognition, perception, and motor control
will be highlighted briefly. These studies have generally followed
one of two designs, by either comparing groups of individuals
with high scores on psychometric schizotypy questionnaires to
those with medium or low scores on these questionnaires in an
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extreme groups approach or by investigating correlations between
schizotypy questionnaire scores and task performance in samples
not selected a priori according to specific schizotypy cut-offs.
Regarding cognition, these studies have shown that higher levels
of schizotypy are associated with impairments in working mem-
ory (79–84), in executive functions [Wisconsin Card Sorting Test,
WCST: (79, 85–87); verbal fluency: (88)], in early sensorimotor
filtering in the prepulse inhibition paradigm [PPI; (52, 89–91)],
in visual backward masking (87), in the flexible adaptation of
behavioral control following cognitive conflict (92), in the latent
inhibition learning paradigm (93), in the recognition and naming
of emotional facial expressions (94, 95), in attention [Continuous
Performance Test, CPT; (96, 97)], in perspective taking regarding
visual stimuli (98) as well as one’s own body (99, 100), and in
Theory of Mind (101). The deficits observed on these tasks are
generally similar in kind to those observed in schizophrenia.
In addition, schizotypy is also associated with perceptual
deficits, such as in the discrimination of auditory (102) and olfac-
tory stimuli (103), and motor impairments. Motor impairments
similar to those observed in schizophrenia were found by assess-
ment of neurological soft signs (104, 105), gait (106), and the preci-
sion of manual motor control (107). Moreover, the smooth pursuit
and antisaccade eye movement deficits that are well described in
schizophrenia (108, 109) are also observed in schizotypy [anti-
saccades: (110–112); smooth pursuit (112–115)]. These include
a reduced ability to match eye velocity to target velocity in the
smooth pursuit task and the failure to inhibit automatic saccades
to a peripheral target in the antisaccade task.
The levels of impairment in different cognitive domains have
also been related to the participants’ specific schizotypy profile.
For example, it was found that people with negative schizotypy
(88, 116–118) as well as disorganized features (87, 88) are particu-
larly impaired in frontally mediated executive functions, whereas
cognition and behavior of people with positive schizotypy suggest
impairments in temporo-limbic circuits (117). Gait abnormalities
were also observed in positive but not negative schizotypy (106).
Of importance in this context is the observation that at least
some of these neurocognitive deficits survive statistical correc-
tion for factors such as intelligence (88, 92) and neuroticism (92,
110), providing further support for the existence of genuine cog-
nitive impairments in people with high levels of schizotypy, over
and above these measures of general (cognitive or emotional)
functioning.
In contrast to the deficits described above, there are only rel-
atively few cognitive functions that are not found to be impaired
in schizotypy. For example, relatively inconsistent findings are
observed in the negative priming paradigm (89, 119) and the
Stroop task (89, 120–126). Additionally, Raine (41) argues that
the level of general intelligence is relatively unimpaired in schizo-
typy. Finally, there are reports of cognitive domains where higher
levels of schizotypy are associated with better performance, for
example, in measures of creativity (127–129).
BRAIN STRUCTURE
Since the early observation of enlarged ventricles (130) in schizo-
phrenia, there have been numerous computed tomography (CT)
and structural magnetic resonance imaging (MRI) studies of
the brain in this disorder. A number of reviews of this litera-
ture are available (131, 132). Overall, these reviews have shown
that patients with schizophrenia, when compared to healthy con-
trols, show gray matter volume reductions in a number of brain
areas. These volume reductions are most pronounced in tempo-
ral, parietal, and frontal cortical areas, hippocampus, amygdala,
and cerebellum. Additionally, there is evidence of ventricular
enlargement. Taken together, these results point to a non-localized
pattern of structural changes, compatible with the hypothesis of
schizophrenia as dysconnectivity syndrome (133–135).
Extending this line of research into schizotypy, structural MRI
studies have investigated associations between the level of schizo-
typy and measures of gray and white matter volume in clinically
unaffected individuals with the aim to search for schizophrenia-
like volumetric changes in high schizotypy. An early 0.15 T MRI
study of 17 healthy subjects showed that higher overall levels of sev-
eral schizotypy scales were associated with a lower area of the left
prefrontal cortex as well as a lower area ratio of prefrontal cortex to
temporal cortex (86), compatible with prefrontal volume reduc-
tions in schizophrenia. A more recent study, however, showed that
healthy individuals with higher levels of positive schizotypy (mea-
sured using the CAPE) had larger whole-brain volumes as well
as posterior cingulate and precuneus volumes (136). This posi-
tive association, which is not in agreement with the hypothesis of
similar brain structural deficits in schizotypy and schizophrenia,
possibly suggests that protective or compensatory mechanisms are
operational in people with high levels of schizotypy but without
the diagnosis of schizophrenia. Such a conclusion is in agreement
with another structural MRI study, which reported a positive asso-
ciation of overall schizotypy levels (SPQ) and cortical thickness in
the frontal lobe (137). However, the same study also observed
a negative association between schizotypy and thalamic volume
(137), compatible with reports of thalamic volume reductions in
schizophrenia (138, 139). Finally, we recently observed that higher
levels of positive schizotypy (35) were associated with volume
reductions in frontal and temporal cortical areas, significantly
overlapping with the pattern of volumetric reductions typically
observed in schizophrenia (140).
These investigations of gray matter volumes in schizotypy have
been most recently complemented by MRI studies of white matter.
A diffusion tensor imaging (DTI) study (141) compared people
with high MMPI-2 (Minnesota Multiphasic Personality Inven-
tory) mean scores in the psychosis-like Sc (Schizophrenia), Pa
(Paranoia), and Pd (Psychopathic Deviate) scales with controls
with low scores. The group with high scores had higher frac-
tional anisotropy (FA) in the left arcuate fasciculus, but lower FA
in the right arcuate fasciculus in fronto-parieto-temporal tracts
and in the corpus callosum. Another study (142) showed that
higher cognitive–perceptual factor scores of the SPQ were associ-
ated with lower white matter integrity in fronto-temporal tracts,
in the bilateral anterior thalamic radiation and the forceps minor.
In addition to these studies of psychometric schizotypy, there
are a number of MRI studies of patients with a clinical diagno-
sis of schizotypal personality disorder (SPD2), a clinical disorder
2It should be pointed out here that high levels of schizotypy on psychometric self-
report questionnaires may result in a diagnosis of SPD, but not necessarily so. For
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with a population prevalence of approximately 3.9%. The findings
from these studies have recently been reviewed in detail elsewhere
(143, 144) and are only summarized briefly here. In short, vol-
ume reductions in SPD are seen in the temporal lobe, similar
to findings from schizophrenia. However, it has also been found
that SPD patients do not display the frontal lobe volume reduc-
tions observed in schizophrenia, possibly reflecting protective
or compensatory processes. Detailed investigations of subcorti-
cal structures support this claim: both schizophrenia and SPD
show volume reductions in the thalamic pulvinar, a structure that
shows prominent connections with the temporal lobe, but not in
the mediodorsal nucleus, which is primarily connected with the
frontal lobe (145). A recent study yielded distributed gray mat-
ter volume reductions in frontal, parietal, and temporal areas
in an important sample of antipsychotic-naïve men with SPD
(143), suggesting that these deficits are not due to (long-term)
antipsychotic treatment.
BRAIN FUNCTION
A still relatively small – but growing – body of work has used fMRI
to investigate the functional neuronal correlates of schizotypy. The
key features and findings from these studies are summarized in
Table 2.
Amongst these studies, there is concrete evidence of similarity
in neural activation patterns between schizophrenia and schizo-
typy. For example, the above mentioned PPI paradigm, a measure
of early attentional processing, was found to be associated with
reduced activation in the insula, putamen, thalamus inferior pari-
etal cortex, hippocampal gyrus, and fusiform gyrus in persons
with high levels of psychoticism (P) (52). These activation reduc-
tions resemble the data obtained from samples of patients with
schizophrenia (146, 147).
Further evidence for brain functional similarity between
schizotypy and schizophrenia was reported by Corlett and Fletcher
(47). In an fMRI study of the Kamin blocking task, these authors
observed an association of lower BOLD signal in the striatum
during unexpected “prediction error” trials with higher schizo-
typy scores and an association between distress with unusual
beliefs and variation in prediction error related signal in the right
frontal cortex. The latter finding is directly compatible with data
from earlier investigations of the prediction error effect in schiz-
ophrenia (148) and following administration of ketamine (149),
a non-competitive NMDA receptor antagonist known to cause
psychosis-like states (150).
Additionally, the already mentioned behavioral deficits in anti-
saccade performance in schizotypy were found to be associated
with reduced activation levels in the striatum, thalamus, cere-
bellum, and occipital cortex (46). This pattern resembles fMRI
studies of volitional saccades in schizophrenia patients [striatum:
example, Raine (33) reported that a diagnosis of SPD was made amongst 55% of
people with SPQ scores in the top 10% of the distribution (compared to 0% of
people from the lowest 10% of the distribution). According to ICD-10, a personality
disorder is characterized by an inflexible, rigid personality that leads to considerable
psychological strain. Therefore, it is important to mention that although all patients
with a SPD diagnosis are likely to have high levels of schizotypy on a psychometric
questionnaire, not all high psychometric schizotypes meet the diagnostic criteria for
SPD.
(151–153)] and their unaffected relatives [striatum: (154), occip-
ital cortex: (155)], although reductions in frontal lobe activation
levels were additionally described in schizophrenia (152) but not
in schizotypy.
Finally, qualitative alterations in the neural processing patterns
underlying a number of other paradigms have also been found
in schizotypy, e.g., in an emotional Stroop task in students with
high levels of positive schizotypy (58). A series of publications on
a sample of students with high CAPE scores showed (i) increased
activation in prefrontal areas in a second order Theory of Mind
task despite unimpaired behavioral performance (55), (ii) reduced
prefrontal control of emotional processing (57), and (iii) altered
activation patterns during the processing of self-related stimuli
(56). In another study, people with high levels of schizotypy were
found to deactivate the dorsal anterior cingulate cortex (ACC)
whilst viewing pictures of social rejection, similar to what has
been found in depressed patients, whereas controls activated the
same structure (59). Huang and colleagues (51) on the other hand
found that people with high SPQ scores showed weaker deacti-
vations in right ACC and stronger deactivations in left posterior
cingulate cortex and right superior temporal gyrus (STG) when
viewing happy faces. Debbané and colleagues (48) examined the
neural correlates of self-reflective processes and positive psycho-
metric schizotypy in adolescence using a trait evaluation task. A
negative association was found between schizotypy and activation
in left lingual gyrus while the participants were rating themselves
compared to others. During the ratings of self vs. control and
other vs. control, schizotypal traits were positively correlated with
activity in posterior cingulate cortex and dorsolateral and dor-
somedial prefrontal cortex. Using a reality monitoring task in
adolescents an association was found between higher SPQ scores
and reduced activation in BA10 during judgments of whether a
word was generated by the participant or the experimenter (53).
In a study on the association between high positive schizotypy
and creativity, Fink and colleagues (50) found similarities in the
brain activation between schizotypy and creativity (as measured
by originality) during creative ideation. Both high scores on the
O-LIFE unusual experiences scale and originality were associated
with reduced deactivation in right parietal brain regions and the
precuneus during creative idea generation. Finally, the implemen-
tation of a dopamine-sensitive procedural learning task in fMRI
yielded positive associations between EPQ-R (39) psychoticism
scores and BOLD signal in striatum, thalamus, insula, and frontal
cortex as well as between STA scores (37) and BOLD signal in right
temporal cortex (49).
The observation that stress is a possible risk factor for schizo-
phrenia (156) has led to an fMRI study of the neuronal response
to stress in participants with high schizotypy (157). Differences
in striatal and limbic activation patterns were found in partici-
pants with negative schizotypy in comparison to controls. These
findings complement an earlier positron emission tomography
(PET) study by the same group, in which participants with nega-
tive schizotypy were found to show greater stress-induced striatal
dopamine release (158).
Apart from these studies of cognitive or emotional activa-
tion paradigms, more recently the investigation of brain func-
tion at “rest,” i.e., in the absence of an overt task, has become
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increasingly instructive. Patients with schizophrenia have been
found to show alterations in the resting-state activation pat-
terns (159). The only resting-state fMRI study of schizotypy
reported positive correlations between SPQ scores and a visual
network in the low frequency range as well as negative correlations
between SPQ scores and an auditory network in young people aged
12–20 years (54).
Several fMRI studies of SPD are also available. A first study by
Koenigsberg and colleagues (160) showed that patients with SPD
displayed reduced activations in distributed fronto-parietal areas
during the retention interval of a visuo-spatial working memory
task. Dickey et al. (161) found that auditory discrimination, a
measure also known to be impaired in schizophrenia, was associ-
ated in SPD with hyper responsive neuronal processing of deviant
tones in temporal and parietal areas. In another study on audi-
tory processing Dickey et al. showed (162) that the recognition
of emotions (sad, happy, sarcastic, neutral) in the prosody of
semantically neutral sentences was unimpaired in SPD; however,
processing was associated with seemingly inefficient activation in
the STG.
The relationship between schizotypy and brain function has
also been investigated using electroencephalography (EEG). For
example, it was found that high SPQ schizotypy is associated with
a reduction in the P100 amplitude during a working memory task,
suggesting the existence of early information processing deficits
(81), similar to what had previously been found in schizophrenia
(163). However, EEG studies have also pointed to later processing
deficits. Klein and colleagues (164) observed a reduction in P300b
amplitude in participants with higher overall schizotypy (SPQ),
complementing P300 amplitude changes that had been reported
in patients with schizophrenia and their relatives (165). In another
study, stronger negativity in the N400 window was found to be
associated with higher scores in the SPQ disorganized dimension
(166). Koychev and colleagues (167) studied a working memory
task and found that participants with high SPQ schizotypy had
reduced network synchronization in the beta and gamma range in
fronto-central and central-occipital regions, compatible with the
observation of disturbed cortico-cortical connectivity in schizo-
phrenia. Another study (99) found that the behavioral deficit in
bodily perspective taking in schizotypy (168) was associated with
an increased duration of activity of the right temporo-parietal
junction. Additionally, there is a replicated association between
reduced P50 suppression in EEG and increased schizotypy (169,
170), especially in the disorganized dimension (171), complement-
ing findings of reduced P50 suppression in schizophrenia patients,
their relatives, and SPD patients (172, 173).
Finally, a number of studies have employed functional near-
infrared spectroscopy (fNIRS) to probe relationships between
brain function and schizotypy. These studies showed that (i)
increased levels of divergent thinking in schizotypy is associate
with stronger activity in right prefrontal cortex in healthy and
schizophrenic subjects (129), (ii) higher overall schizotypy scores
(SPQ) are associated with reduced activity in frontal cortex during
the recognition of one’s own face but with increased activity dur-
ing the “Reading the Mind in the Eyes” task (174), and (iii) high
schizotypal (SPQ) participants show stronger activity and a greater
right> left asymmetry during a letter fluency task (175, 176).
PSYCHOPHARMACOLOGY
Psychopharmacological methods have also been drawn upon
to elucidate the neural basis of schizotypy as well as possible
similarities with schizophrenia. A central observation in schiz-
ophrenia research is the finding of increased striatal dopamine
release that is seen in the patients following the acute administra-
tion of amphetamine. Imaging studies have shown that patients
with schizophrenia, both in the acute phase and in remission,
show amphetamine-induced reductions in D2 and D3 dopamine
receptor binding potential in the striatum (177, 178). Similar
findings were obtained in patients with schizotypal personal-
ity disorder (179). Importantly, a relationship between striatal
dopamine release after amphetamine and SPQ schizotypy was
observed in a sample of non-clinical volunteers (180), providing
support for a shared dopaminergic dysfunction in schizotypy and
schizophrenia.
In a large, multi-center pharmacological study of SPQ schizo-
typy it was observed that the D2/D3 receptor antagonist amisul-
pride improved working memory and verbal fluency performance
in persons with high levels of schizotypy but worsened it in
medium schizotypal controls (181). Data from the same study
showed that administration of 7 mg risperidone led to deteri-
oration in antisaccade task performance in medium schizotypy
controls, whereas in high schizotypy a non-significant tendency
toward improvement was observed (182), compatible with the
improvements in antisaccade performance seen in schizophrenia
with risperidone treatment (183, 184). Together, these data suggest
that persons with high schizotypy benefit from antipsychotic com-
pounds similar to patients with schizophrenia, or at least tolerate
them, whereas controls do not. Finally, an EEG study of the seman-
tic processing of words (185) showed that anterior components
of the increased N400 potential in high schizotypy were reduced
through a one-off administration of the antipsychotic olanzap-
ine. This effect resembles findings from schizophrenia research
(186, 187) and suggests a dampening of increased salience in high
schizotypy, as in low schizotypal subjects there was no such effect
of olanzapine.
Taken together, these pharmacological studies yield highly
interesting evidence of similarity between schizotypy and schiz-
ophrenia with respect to the neurocognitive effects of psy-
chotomimetic and antipsychotic compounds. However, evidence
of differences between these groups has also been obtained. For
example, the dopamine increasing substance levodopa leads to
improvements in a mental rotation task in people with high posi-
tive schizotypy, whereas cognitive improvements in schizophrenia
tend to be observed after treatment with dopamine antagonists.
This pattern of effects was explained by drawing upon the non-
linear relationship between dopamine and performance along an
inverted U-function (106).
SUMMARY OF GENETICS, COGNITION, AND NEUROBIOLOGY
Overall, the studies described in the previous sections provide sup-
port, across a number of methods and functional domains,of alter-
ations in cognition, perception, motor control, and neurobiology
in schizotypy. Importantly, many of these alterations are qualita-
tively similar to the impairments seen in schizophrenia, supporting
the notion of similarity between schizotypy and schizophrenia.
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However, evidence of discontinuities is also reported in some cog-
nitive tasks that do not consistently show impairments in schizo-
typy, such as the negative priming and Stroop tasks. Additionally,
better performance in schizotypy has been observed on measures
of creativity and some structural neuroimaging evidence exists of
possibly protective or compensatory neural resources in schizo-
typy. Clearly, these putatively preserved (or enhanced) functions
and structures need to be investigated further.
SCHIZOTYPY: IMPORTANCE AND IMPLICATIONS FOR
SCHIZOPHRENIA RESEARCH
Taken together, the cited studies support the assumption of a con-
tinuum between schizophrenia and schizotypy at different levels
of analysis (6). Accordingly, implications of our current under-
standing of schizotypy to schizophrenia research are based at least
in part on the continuum hypothesis, as detailed in the following
section.
First, the documentation of such a continuum provides impor-
tant clues regarding the etiology of schizophrenia (5, 15). Con-
tinuously distributed (and reliably measured) phenotypes are
suggested to be the result of multiple etiological factors. A multi-
factorial etiology of schizophrenia has frequently been postulated.
Accordingly, current research focuses on multiple gene loci (188)
as well as several environmental risk factors (156). Of further
interest in this context is the assumption that highly schizo-
typal individuals may be undetected carriers of schizophrenia risk
alleles, which may provide one answer to questions from evolu-
tionary biology concerning the frequency of schizophrenia in the
population (128, 189).
Second, in addition to providing clues regarding the etiology of
schizophrenia, schizotypy is an important topic for investigations
in its own right, not only because of the documented neurocogni-
tive impairments but also because of its associations with a number
of maladaptive behaviors and psychiatric symptoms. For example,
high levels of schizotypy are associated with cigarette smoking
(190–192) and consumption of drugs such as cannabis (193, 194),
negative affect, post-traumatic stress disorder, anxiety disorders
and depression (195–198), and lower social, educational, and pro-
fessional levels of functioning (197, 199–207). Overall, it can be
concluded that people with high levels of schizotypy display mal-
adaptive behaviors and psychiatric symptoms and suffer a lower
quality of life (197, 208). Therefore, a thorough characterization
of the cognitive and neural correlates of schizotypy can lead to an
improved understanding of these disturbances and development
of appropriate therapies.
Third, there may also be merits of studying schizotypy as a
model system of schizophrenia. A particularly promising appli-
cation of such a model system is in relation to antipsychotic
and pro-cognitive drug development, an area of clear need in
the treatment of schizophrenia (209, 210). The methodological
advantages of such a model system include the availability of
cheap, reliable, and objective psychometric questionnaires (17,
190). Additionally, continuously distributed data possess high
statistical power (211). Finally, studies of high schizotypes are
not confounded by problems such as long-term pharmacological
treatment or chronic hospitalization as is frequently encountered
in schizophrenia research.
Fourth, some authors have argued that a conceptualization
of schizophrenia as a spectrum disorder may lead to increase
in psychoeducational and psychotherapeutic treatment success.
For example, David (5) and Johns and van Os (15) argue that
dimensional definitions of the symptoms of schizophrenia are
less stigmatizing than categorical diagnoses, a factor that could
contribute beneficially to treatment outcome.
Overall it has been argued (190, 212) that the continuum
approach to etiological research possesses higher validity than the
categorical approach. The latter, on the other hand, may yield bet-
ter reliability and has of course unrivaled usefulness in clinical
communication and decision making with regards to treatment
strategies.
It is also important to point out differences between the
schizotypy paradigm and other phenotypic and genotypic spec-
trum sample strategies within the wider context of schizophrenia
research. For example, the popular and successful approach of
studying the biological relatives of schizophrenia patients draws
upon the principle of a genetic continuum (213). Two fundamen-
tal findings stemming from this large body of work are (i) the
observation of schizophrenia-like signs and symptoms in the rela-
tives and (ii) the identification of neural and cognitive endopheno-
types. Endophenotypes, or intermediate phenotypes, are markers
of the genetic vulnerability to the illness and may help to improve
our understanding of the neuronal and behavioral effects of risk
genes (214, 215).
A second, important schizophrenia-spectrum population that
is currently under intense investigation is individuals at partic-
ularly high risk for developing the illness. Such individuals are
identified from the general population on the basis of different
trait and state factors and have been found to have a high frequency
of conversion to schizophrenia (216), higher than that observed in
psychometric schizotypy (217).
The schizotypy approach described here complements these
genetic and high-risk approaches by adopting a psychometric
criterion for the definition of this spectrum population.
CONCLUSION
In this article, we reviewed evidence of putative overlap between
schizotypy and schizophrenia. We argued first that this overlap
is apparent at the phenomenological level, with schizotypy traits
resembling, in attenuated form, the signs and symptoms of schiz-
ophrenia. Importantly, we then provided evidence from genetic,
cognitive, and neurobiological studies supporting the assump-
tion that schizotypy shows significant similarity with schizophre-
nia also at these levels, suggesting that the observed similarity
at the phenomenological level may not be trivial. Future work
will be required to further characterize the boundary between
high schizotypy and schizophrenia. Another area of research that
deserves further attention concerns the identification of differ-
ences between schizotypy and schizophrenia. These may point to
protective or even compensatory mechanisms that prevent high
schizotypes from developing full-blown schizophrenia.
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